Genotyping Industry Growth Expected to Reach $51.43 Billion by 2029 at a CAGR of 17.9% | Segmentation and Growth Opportunities
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Genotyping Market Growth in 2025?
The genotyping market has seen a substantial growth in the recent years. It is projected to increase from $23.04 billion in 2024 to $26.63 billion in 2025, with a compound annual growth rate (CAGR) of 15.6%. The impressive growth experienced during the historical period can be owed to factors such as government schemes and funding, drastic reduction in genotyping costs, the proliferation of biobanks and genetic databases, rising incidence of genetic disorders, and advancements in pharmacogenomics and drug development.
What Is the Forecast for the Genotyping Market Size Through 2029?
Projections indicate swift expansion in the genotyping market in the upcoming years, with its value expected to rise to $51.43 billion in 2029, by growing at a compound annual growth rate (CAGR) of 17.9%. The forecasted increase in this period is tied to the wider acceptance and application in clinical diagnostics, increasing appeal of personalized medicine, an uptick in research and development activities, and a wider application scope in agriculture and livestock. The speculated trends in this period involve growing appeal for pharmacogenomics, advancements in next-generation sequencing (NGS), development in precision medicine initiatives, surge in direct-to-consumer (DTC) genetic testing, and heightened interest in cancer genomics and customized therapies.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12059&type=smp
What are the Key Market Players in Genotyping Market and How They’re Evolving?
Major companies operating in the genotyping market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Eurofins Scientific SE, Agilent Technologies, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv, Takara Bio Inc., Integrated DNA Technologies Ltd., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies, Macrogen Inc., Pacific Biosciences of California, Standard BioTools Inc., GENEWIZ, Transnetyx, Agena Bioscience Inc., Genotypic Technology Pvt Ltd., BMG LABTECH GmbH, Bioline, Biofortuna Limited, Xcelris Genomics
What Are the Primary Growth Drivers in the Genotyping Market?
An increase in cancer and genetic disorders is anticipated to fuel the genotyping market’s expansion. A diverse array of diseases that can originate in just about any part of the human body is what comprises cancer, while genetic disorders are illnesses in whole or in part caused by an alteration in the typical DNA sequence. Genotyping is a tool that experts can utilize to scrutinize DNA abnormalities like single nucleotide alterations, copy number deviations, and significant alterations in the DNA’s structure. Genotyping or genetic testing can help identify certain genetic mutations that might boost a person’s vulnerability to specific cancers. For instance, according to the World Health Organization, a public health agency based in Switzerland, in 2022, almost 20 million new cancer cases were documented leading to 9.7 million deaths. At the same time, around 53.5 million people survived for five years post their cancer diagnosis. In addition, according to Gene People UK, a registered charity in the UK, it’s estimated that 1 out of every 25 children suffers from a genetic disease. This denotes that approximately 30,000 infants and children are being newly diagnosed in the UK each year, and over 2.4 million children and adults suffer from a genetic disorder. Consequently, the growing ubiquity of cancer and genetic disorders is propelling the advancement of the genotyping market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12059&type=smp
What Are the Leading Segments in the Global Genotyping Industry?
The genotyping market covered in this report is segmented –
1) By Product And Services: Instruments, Reagents And Kits, Bioinformatics, Genotyping Service
2) By Technology: Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction, Matrix-Assisted Laser Desorption Or Ionization (Maldi-Tof) Mass Spectrometry, Other Technologies
3) By Application: Pharmacogenomics, Diagnostics And Personalized Medicine, Animal Genetics, Agricultural Biotechnology, Other Applications
4) By End-User: Pharmaceutical And Biopharmaceutical Companies, Diagnostics And Research Laboratories, Academic Institutes, Other End-Users
Subsegments:
1) By Instruments: Sequencers, PCR Machines, Microarrays, Genotyping Platforms
2) By Reagents And Kits: DNA Extraction Kits, PCR Reagents, SNP Genotyping Kits, Next-Generation Sequencing (NGS) Kits
3) By Bioinformatics: Data Analysis Software, Genomic Data Management Tools, Cloud-based Solutions
4) By Genotyping Services: Contract Research Organizations (CRO) Services, Custom Genotyping Services, Sample Preparation Services
What Are the Key Market Trends in the Genotyping Industry?
The advent of product innovation is a predominant trend in the genotyping market. To remain competitive, companies in this sector are resorting to ingenious solutions. Neogen, an American food safety company, in collaboration with Gencove Inc., another American company specializing in a platform for genomic discovery, launched InfiniSEEK in May 2022. This is an innovative and economical solution for full genome sequencing and targeted Single Nucleotide Polymorphism (SNP) analysis. It’s the first complete genome and genotyping sequencing solution tailored specifically for cattle breeders. InfiniSEEK provides a reliable platform to manage over 400 bovine genetic traits and conditions, uncover new variables that influence desirable traits, and reduce selection bias by sequencing a larger or full population. This new service offers consumers an abundant and affordable data source for global cattle profiling, merging genome-wide sequencing data, specific genetic attributes, and markers of parentage.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/genotyping-global-market-report
What Is the Regional Outlook for the Genotyping Market?
North America was the largest region in genotyping market in 2024. The regions covered in the genotyping market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12059
This Report Delivers Insight On:
1. How big is the genotyping market, and how is it changing globally?
2. Who are the major companies in the genotyping market, and how are they performing?
3. What are the key opportunities and risks in the genotyping market right now?
4. Which products or customer segments are growing the most in the genotyping market?
5. What factors are helping or slowing down the growth of the genotyping market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
